More stories

  • in

    New and used car prices keep climbing. Don’t expect relief anytime soon

    An estimated 89% of auto shoppers are paying more than sticker price or within 5% of it.
    The average price paid for a new car is $45,872, above the average MSRP of $45,209.
    With used car prices up, as well, your trade-in also is worth more than you may think.

    When it comes to car shopping these days, sticker price may mean sticker shock.
    New and used car prices continue to spurt higher amid strong demand and tight inventory. While a manufacturing slowdown has improved slightly, there won’t be a return to normal anytime soon for car buyers.

    “The typical dealership experience that consumers are familiar with — walking dealer lots with rows and rows of cars, negotiating over price and getting many incentives — is not likely to return this year because there are 4.5 [million] to 5 million consumers on the sidelines waiting for cars,” said Tyson Jominy, head of data and analytics for J.D. Power.
    More from Personal Finance:Auto insurance expected to cost 5% more in 2022How to insure your trip amid airline cancellationsYour best money moves before interest rates rise
    “This pent-up demand will keep inventories low and prices high throughout most of 2022,” Jominy said.
    An ongoing global shortage of microchips — key components needed for today’s autos to operate — that began in 2020 continues to slow down manufacturers’ production of new vehicles, which has translated into demand outpacing supply.
    “It’s slightly better in the sense that there is no more drop-off of inventory — it’s not getting any worse,” said Ivan Drury, senior manager of insights for Edmunds.com. “But we’re still talking many months out until it starts looking more normal.”

    The average transaction price for a new car is now higher than the manufacturer’s suggested retail price, or MSRP: $45,872 versus $45,209, according to the most recent data from Edmunds.
    An estimated 89% of shoppers are paying more than sticker price or within 5% of it, Jominy said.
    Part of the reason for record transaction prices is that automakers have slashed their discounts because, generally speaking, they don’t need to offer big incentives to sell cars right now. 

    In other words, new cars aren’t hanging around long once they arrive on a dealer lot: In December, an estimated 57% of cars sold within 10 days of delivery, according to J.D. Power. The average time, overall, for a new car to sell from the lot is 17 days, a record low and down from 49 days a year ago.
    Demand also has spilled into the used-car market, where buyers are paying an average $29,011, up 27.9% from a year ago, Edmunds’ data shows. That ranges from an average $14,124 for 9-year-old cars to $30,334 for a 3-year-old vehicle.

    One bright spot, Drury said, is that the demand for used cars has pushed trade-in values well above normal.
    “Shop that trade-in,” he said. “Don’t go off old assumptions about mileage or depreciation, because all that stuff is out the door.”
    And while you should be prepared for there being little wiggle room on the price of the car, you may be able to negotiate on the value assigned to your trade-in.

    Additionally, interest rates are generally low right now.
    “You can still get money cheap,” Drury said, adding that there are still some 0% or 0.9% financing deals available, depending on the make and model you’re looking at. Otherwise, the average interest rate for a new-car loan is under 4%, according to Bankrate. 
    If you have flexibility in the timing of your purchase and are not finding what you want on dealer lots, it may be worth ordering your car.
    “While it may take four to eight weeks for the vehicle to arrive, it will be built to your exact specifications, such as a trim and color,” Jominy said. “And now some automakers will offer incentives to pre-order that aren’t available to consumers buying what’s in stock.”

    WATCH LIVEWATCH IN THE APP More

  • in

    Jim Cramer's week ahead: It's an 'odd time' for markets but earnings matter again

    Monday – Friday, 6:00 – 7:00 PM ET

    CNBC’s Jim Cramer on Friday outlined his game plan for next week after Wall Street concluded its first five trading sessions of 2022.
    The “Mad Money” host said it’s “a bit of an odd time” for markets right now.
    However, he said earnings are back in focus and will help dictate stock moves.

    CNBC’s Jim Cramer on Friday outlined his game plan for next week after Wall Street concluded its first five trading sessions of 2022.
    The “Mad Money” host said it’s “a bit of an odd time” for markets right now, “almost as if many stocks have to take their medicine and then get back on track. ”

    “This week we saw the unprofitable techs get a drubbing, which then spread into the more mature, profitable ones,” Cramer said. However, he added, “it’s a heck of a lot easier to buy the stock of an established company that’s actually making money. Yep, earnings are what matters again, tangible GAAP earnings.”
    Here’s what Cramer is watching for next week. All revenue and earnings estimates are from FactSet.

    Arrows pointing outwards

    Jim Cramer’s game plan for the trading week of Jan. 10.
    Mad Money with Jim Cramer

    Monday: JPMorgan Health Care Conference and Tilray earnings

    JPMorgan Health Care Conference
    Now in its 40th year, the JPMorgan Health Care Conference is a hugely influential event, Cramer said, explaining that company presentations made there are known to move stocks. The virtual conference starts Monday and lasts through Thursday.
    Tilray

    Q2 2022 earnings before the bell; conference call at 8:30 a.m. ET Monday
    Projected loss: Loss of 7 cents per share
    Projected revenue: $200 million

    Tuesday: Albertsons earnings and Dell Technologies investor meeting

    Albertsons

    Q3 2021 earnings before the open; conference call at 8:30 a.m. Tuesday
    Projected EPS: 61 cents
    Projected sales: $16.34 billion

    While shares of Albertsons have pulled back from their recent highs, Cramer said he thinks the grocery chain’s stock has more room to run. He suggested that investors who are interested in owning the stock buy some Monday ahead of Tuesday’s quarterly print.
    Dell Technologies

    Virtual fireside chat at 3:30 p.m. ET Tuesday

    Chairman and CEO Michael Dell is set to speak at Bank of America’s View from the Top CEO Series, and Cramer said he’s interested to hear the executive’s outlook now that Dell completed its spin-off of VMWare. Cramer said he personally believes the future is bright, recommending investors buy shares before and after Tuesday’s scheduled presentation.

    Wednesday: KB Home earnings

    KB Home

    Q4 2021 earnings after the close; conference call at 5 p.m. ET Wednesday
    Projected EPS: $1.77
    Projected revenue: $1.71 billion

    Investors are closely watching the impact that higher interest rates have on mortgage rates and, by extension, demand for homes, Cramer said. He said he thinks KB Home’s stock could move higher if it reports Wednesday because he expects strong results.

    Thursday: Delta Air Lines earnings

    Delta Air Lines

    Q4 2021 earnings before the bell; conference call at 10 a.m. ET Thursday
    Projected EPS: 13 cents
    Projected revenue: $8.86 billion

    Cramer said investors will be focusing less on how Delta’s business has been and more on how the company expects it to be as the Covid pandemic progresses.
    “Do they think business travelers will come back? Can they staff their planes sufficiently? Are fares going higher?” Cramer asked rhetorically. “While I like Disney for my charitable trust and think that American Express can keep running, I’m skeptical about how far Delta’s stock can go in this environment.”

    Friday: Earnings from Wells Fargo, JPMorgan, BlackRock and Citigroup

    Wells Fargo

    Q4 2021 earnings before the bell; conference call at 10 a.m. ET Friday
    Projected EPS: $1.10
    Projected revenue: $18.67 billion

    Cramer, whose charitable trust has a sizable position in Wells Fargo, said he believes the bank is going to have a strong 2022. However, he acknowledged the stock is off a hot start, up roughly 14% year to date already. He said it’s not clear that pace can continue, but future pullbacks may present buying opportunities.
    JPMorgan

    Q4 2021 earnings before the open; conference call at 8:30 a.m. ET Friday
    Projected EPS: $3.00
    Projected revenue: $29.85 billion

    CEO Jamie Dimon “tends to be very optimistic, but also mixes in a few Molotov’s along with his otherwise easy-to-down economic cocktails,” Cramer said.
    BlackRock

    Q4 2021 earnings before the bell; conference call at 8:30 a.m. ET Friday
    Projected EPS: $10.10
    Projected revenue: $5.12 billion

    Cramer said he expects a strong quarter, adding that he’s looking forward to hearing insights into the company, the market and the economy from BlackRock CEO Larry Fink.
    Citigroup

    Q4 2021 earnings before the open; conference call at 11 a.m. ET Friday
    Projected EPS: $1.55
    Projected revenue: $16.92 billion

    Cramer said he’s watching to see if CEO Jane Fraser can offer commentary that’s optimistic enough to move Citigroup’s stock higher, allowing it to catch up with some peers. Additionally, he said he’s looking for more information about Citi pausing its share repurchase program in December.
    Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.
    Disclosure: Cramer’s charitable trust owns shares of Wells Fargo and Disney.

    WATCH LIVEWATCH IN THE APP More

  • in

    Cramer's lightning round: CVS Health is a good long-term buy

    Monday – Friday, 6:00 – 7:00 PM ET

    It’s that time again! “Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.

    Loading chart…

    WSFS Financial: “I like that. It’s a good bank in a good area. Let’s try to get them on. I’ve admired them for about 30 years.”

    Loading chart…

    CVS Health: “I’m going to say yes [for a long-term investment], aided by the fabulous Lisa Gill [of JPMorgan] who told me at $15 to buy it and says don’t mind that it’s at $100. Buy it again.”

    Loading chart…

    Roblox: “Roblox is the kind of stock I’m willing to plow through this period because it is such an original, terrific way to play the metaverse.”

    Loading chart…

    Paymentus Holdings: “I know it’s payment technology. Those stocks are under so much pressure, but it does make money. Let me give it more scrutiny and come back to you.”
    Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

    WATCH LIVEWATCH IN THE APP More

  • in

    Apology notes, store closures and reduced hours: Here's how retailers are handling omicron surge

    Retailers and restaurants no longer face the looming threat of government shutdowns, but are struggling with understaffing as omicron compounds the existing worker shortage — and threatens to exacerbate supply chain challenges.
    Macy’s, Apple and Walmart are among the retailers that have reduced hours or temporarily shuttered locations with the latest wave of Covid cases.
    Shoppers’ appetite for spending has remained high, though some Americans are trimming back visits to public places like restaurants, shopping malls and coffee shops, according to a recent survey by Coresight Research.

    A shelf stands empty as customers shop in Columbus, Ohio.
    Matthew Hatcher | Getty Images News | Getty Images

    Slashing store hours, temporarily shuttering locations and sending apology letters to customers for long lines and delayed appointments.
    These are the some of the unusual steps that retailers and restaurants are taking as Covid cases spike across the country, fueled by the fast-spreading omicron variant.

    Companies are no longer worried about state and local governments shutting businesses down.
    Instead, the businesses are coping with a shortage of workers as people call out sick, get exposed to the virus or scramble to find childcare. And the threat of more supply chain woes looms as the highly contagious variant spread across the globe.

    “There is no question that staffing is definitely a big issue this time around,” said Stephanie Martz, the chief administrative officer and general counsel of the National Retail Federation. “It was maybe less measurable when we were at a point in the pandemic when so much was closed and everything was so scaled down.”
    “I don’t know if I would go as far as to say that we have an unprecedented number not being able to work, but it’s high,” she said. “It’s really high.”
    Covid cases have surged. The U.S. is reporting a seven-day average of about 600,000 daily new cases, an all-time high and up 72% from the week prior, according to a CNBC analysis of data compiled by Johns Hopkins University through Thursday.

    Source: Lauren Thomas, CNBC

    A soaring number of sick, exposed or overworked employees has caused retailers and restaurants to take unusual steps as their existing labor problems worsen. Macy’s cut store hours at locations across the country for the rest of this month. Walmart temporarily closed nearly 60 stores in December in coronavirus hot spots. And other employers, including Starbucks, Chipotle and Nike have been forced to close some of their doors as they simply don’t have enough people to keep them open.
    Walgreens sent an apology email to customers this week, acknowledging customer complaints about long checkout lines, out-of-stock items and delays for Covid vaccine or test appointments. In the note, the company’s leaders mentioned the many tasks that pharmacy staff are juggling — namely, giving over 55 million Covid vaccines and more than 23 million Covid tests, while still filling over a billion prescriptions annually.
    “There’s been a high level of stress in the system,” Walgreens Chief Financial Officer James Kehoe said Thursday on a company earnings call. He said the company is going to spend roughly $120 million more on labor to help its stretched-thin staff.

    Morgan Harris is store owner of the Green Bambino in Oklahoma City. She said the store, which sell baby supplies from toys to strollers, has struggled with understaffing and she worries it may get worse.
    Morgan Harris

    Regular hours go ‘out the window’

    For short-handed retailers, reducing hours has become one of the first logical moves to make, said Craig Rowley, a senior client partner at Korn Ferry and head of the firm’s retail practice. Some stores are trimming back on weekdays when only a small percentage of sales take place compared with busier weekends, he said.
    He said pandemic-related changes may prompt retailers to permanently rethink store hours, particularly as more sales move online.
    “The labor shortages from [Covid] goes out to almost any customer-facing business,” said Rowley. “Retailers and restaurants are facing this in spades.”
    Morgan Harris owns Green Bambino, a Oklahoma City store that sells baby supplies including onesies, diapers and toys. She said she has had to toss out one of the cardinal rules of retail as she operates with a staff of four people – less than half the 10 to 15 person staff she expected to have. The store has had to switch its schedule. It is now open five days a week instead of seven.
    Now, she sees some corporate giants doing the same as they get hit by the “Great Resignation” and squeezed further by the omicron wave.
    “It used to be in retail you never changed your hours,” she said. “That’s out the window.”
    Some companies have gotten better at using technology to notify customers about staffing shortages or store closures. For example, an understaffed Chipotle location can turn off digital orders coming from its app and focus on in-store transactions instead while nearby restaurants fulfill delivery and online orders.
    Rowley said the good news is that retailers and restaurant chains have at least survived the holiday rush. “Staffing levels aren’t what they were pre-Christmas, so companies do have that advantage,” he said.
    Retailers may even be able to ask temporary holiday hires to stick around and work additional hours into the new year, he added.
    Harris, however, said she worries Green Bambino may have to cope with a leaner staff, even as its sales jump. Its annual revenue grew to nearly $900,000 last year — 23% higher than 2020 and 14% higher than pre-pandemic sales in 2019.
    Job applications have slowed to a trickle, despite enlisting a recruiter’s help. And she said the omicron wave hasn’t yet hit the region — which could mean more employees calling out sick.
    “I would anticipate our staff shrinks further, not gets bigger,” she said. “I have very little hope that all of the sudden we are going to find all of these amazing people and bring them on.”
    Plus, she said, the latest wave of the pandemic could further delay the return to steady shipments of popular baby items, such as car seats and strollers. The store is getting out of the furniture business due to backlogged shipping times and higher freight costs. It stopped accepting deposits for many items, since it could not predict if — or when — those big-ticket items would come back into stock.
    “I don’t feel like I’m reinventing the business every two weeks like I was in 2020, but we have no idea what businesses we will have to run post-pandemic,” she said. “The uncertainty is here to stay several more months, if not longer.”

    A customer waits for a contactless curbside pickup at the Recreational Equipment Inc. (REI) flagship store in Seattle, Washington, U.S., on Thursday, May 14, 2020.
    Chona Kasinger | Bloomberg | Getty Images

    Muscle memory

    Shoppers, on the other hand, have kept spending — even if some browse online instead of in aisles or switch to curbside pickup or home deliveries, which have become part of their muscle memory.
    Avoidance of some public places has crept up slightly again, according to a survey by Coresight Research of more than 500 U.S. consumers on Dec. 27 compared with prior weeks. A rising number of consumers said they are pulling back on activities like international travel and use of public transit. Nearly 66% of respondents said they are avoiding any public place — up from 62% when the survey was conducted Dec. 13.
    About 38% of respondents said they were avoiding shopping centers and malls and about 33% said they were avoiding restaurants, bars and coffee shops versus 32% and 30%, respectively, two weeks prior.
    However, the company’s survey did not show any significant change in what consumers were buying or how much they were spending.
    The restaurant industry may be entering yet another downturn. Restaurant analytics firm Black Box Intelligence found that restaurant sales declined for the first time since mid-March in the week ended Dec. 26, but chalked up the reversal in large part to Christmas falling on a weekend this year, as well as the omicron surge.
    OpenTable data shows that seated diners from online, phone and walk-in reservations are down in the United States in the first week of 2022 compared with pre-pandemic levels, but consumers may be switching to takeout or trying to stick to New Year’s resolutions.
    If that plays out, it could mean Americans spend on stuff instead of services. Holiday sales were on track to hit a record high of up to 11.5%, according to the National Retail Federation. (The final numbers won’t be released until late next week.)
    The retail trade group’s chief economist, Jack Kleinhenz, said consumers’ heightened appetite for goods and reluctance to spend on trips, dining out and other types of spending could fuel inflation.
    John Mercer, Coresight Research’s head of research, said for the most part, the shopper has appeared to “roll their eyes, take a deep breath and sigh and then kind of carry on as much as they can as normal.”
    “It’s quite different this time,” he said. “Consumers have been double jabbed, triple jabbed. They have been through this before. It’s really obvious that in other countries, omicron in general is much weaker.”
    Nearly three in four Americans are fully vaccinated, as of Thursday, according to the Centers for Disease Control and Prevention. So far, 73 million people have received a booster shot — representing roughly 22% of the U.S. population. And on Wednesday, the CDC greenlighted Pfizer and BioNTech’s Covid booster shots for children ages 12 to 15.
    And there is some evidence that omicron is milder than previous variants, according to World Health Organization officials.
    That may be starting to change the outlook for Americans who are getting sick. The country is reporting an average of about 1,250 deaths per day, Hopkins data shows, well below the record numbers seen following last year’s holiday season when the daily average held above 3,000 for about a month starting in January 2021. The death toll tends to lag rises in case counts and hospitalizations, however.
    NRF’s Martz said both retailers and consumers have a better grasp on coronavirus. That’s led to a heavier emphasis on tools like booster shots, at-home Covid tests and better masks instead of wiping down counters or installing plexiglas screens.
    One way the industry is pressing forward is by throwing its annual conference in person. NRF’s Big Show will be held next week in New York City at the Javits Center — previously a mega-center for Covid vaccines and potentially the source of the first known instance of omicron spreading within the United States.
    Martz acknowledged that the conference will look different than pre-pandemic. All attendees must wear a mask and show proof of vaccination. Booths on the showroom floor may have less staffing. And the trade group will hand out at-home Covid tests and host a mobile testing unit.
    As many as 20,000 attendees are expected — roughly half of the attendance in 2019.
    Still, she said, it feels right to press forward as frontline retail employees continue to go to work in person day after day.
    “We feel this is now an appropriate time to get back to together in some fashion,” she said, even if “it won’t look like our shows have in the past.”
    CNBC’s Nate Rattner, Lauren Thomas, and Amelia Lucas contributed to this report.

    WATCH LIVEWATCH IN THE APP More

  • in

    Jim Cramer says these 5 'old tech' stocks could have a big year in 2022

    Monday – Friday, 6:00 – 7:00 PM ET

    CNBC’s Jim Cramer on Friday laid out an investment case for five legacy technology companies that he believes could post strong returns in 2022.
    The “Mad Money” host touted Apple, Cisco, IBM, Microsoft and Oracle.
    Those companies should be able to perform well even as the Fed tightens policy, Cramer said.

    CNBC’s Jim Cramer on Friday laid out an investment case for five legacy technology companies that he believes could post strong returns in 2022.
    The “Mad Money” host said the following stocks fit within his main theme for the year, which is investing in profitable companies that produce tangible goods: Apple, Cisco, IBM, Microsoft and Oracle.

    “While most of the money-losing cloud based software stocks are now off limits, there are plenty of tech names that make real things and generate real profits,” Cramer said, contending they can perform well despite the Federal Reserve’s tightening of monetary policy.
    “What you want here are boring, mature companies—the kind that are often derisively referred to as ‘old tech,'” Cramer added. “I say out with the new, and in with the old.”

    Apple

    “Even with the stock’s 34% run last year … it’s now pulled back $10 from its highs earlier this week thanks to the tech meltdown. Whenever you get a buying opportunity like this with Apple, you’ve got to take it,” Cramer said.
    Cramer said he believes Apple will benefit from pent-up demand that consumers can unleash once supply-chain issues subside. The iPhone maker’s “monster” share repurchase program is even more beneficial against the backdrop of a tightening Fed, Cramer said.

    Cisco

    Shares of Cisco have been strong since late November, Cramer said, as investors began to look past the company’s recent earnings reports.

    “Those last two quarters weren’t bad because of demand. We’re actually seeing a surge in enterprise tech spending; the problem was the supply chain crisis,” said Cramer, who also touted the computer networking company’s move into software and the recurring revenue streams that accompany it.
    “[Cisco CEO Chuck Robbins] says things should start turning in the second half of Cisco’s fiscal year, which starts February. I’m inclined to believe him because he’s a real straight-shooter,” Cramer said.

    IBM

    Cramer said he wouldn’t be surprised if IBM’s stock sells off when the company reports earnings in a couple weeks, but he holds a favorable view over the longer-term.
    “I still like IBM for two very simple reasons: it’s incredibly cheap, selling for 12 times earnings, and even after the Kindryl spin-off, they’ve kept their pre-breakup dividend, which means the stock’s got a 4.9% yield,” Cramer said.
    He also said he’s on board with CEO Arvind Krishna’s “mission to unlock value at any cost.”

    Microsoft

    “This one ran up about 51% last year, but thanks to the sell-off in recent weeks, you’re getting a very nice buying opportunity here. The stock’s down 10% from its late November highs. That usually doesn’t’ happen,” Cramer said. “Microsoft is exactly the kind of tangible tech story that should work when the Fed starts hitting the brakes to stop the economy.”

    Oracle

    Even after its breakout 2021, Cramer said he still thinks Oracle’s stock is cheap. The enterprise software giant’s most-recent quarter was fantastic, Cramer said. However, the stock has given up the gains it had post-report, due in part to Wall Street’s negative reaction to Oracle’s plans to buy electronic medical records company Cerner.
    “This is another one where the recent pullback’s letting you in at an amazing price,” Cramer said.
    Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.
    Disclosure: Cramer’s charitable trust owns shares of Microsoft, Apple and Cisco.

    WATCH LIVEWATCH IN THE APP More

  • in

    FDA shortens Moderna booster waiting period to 5 months for adults

    The shortened waiting period for boosters comes as data shows that two doses do not provide strong protection against symptomatic infection from omicron.
    Boosters were shown to be up to 75% effective at preventing such infection, according to a key U.K. study.
    Earlier this week, the FDA authorized everyone 12 and older who received the Pfizer and BioNTech vaccine to get a booster at least five months after their second dose.

    A healthcare worker prepares a syringe with the Moderna COVID-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the COVID-19 pandemic in Manhattan in New York City, January 29, 2021.
    Mike Segar | Reuters

    The Food and Drug Administration on Friday authorized adults 18 and older who are vaccinated with Moderna to get a booster shot five months after their second dose, shortening the waiting period by a month.
    Earlier this week, the FDA authorized everyone 12 and older who received the Pfizer and BioNTech vaccine to get a booster at least five months after their second dose, also down from six months.

    The Centers for Disease Control and Prevention originally recommended Moderna boosters for adults in October. The CDC lowered eligibility for Pfizer boosters to those 12 and older on Wednesday.
    Moderna and Pfizer are the most commonly administered vaccines in the U.S.
    The shortened waiting period for boosters comes as data shows that two doses do not provide strong protection against symptomatic infection from omicron, the dominant variant in the U.S., though they do still offer good protection against severe illness.

    Boosters were shown to be up to 75% effective at preventing such infection, according to a report published last week by the U.K. Health Security Agency.
    “Vaccination is our best defense against Covid-19, including the circulating variants, and shortening the length of time between completion of a primary series and a booster dose may help reduce waning immunity,” said Dr. Peter Marks, head of the FDA group responsible for vaccine safety.

    Moderna CEO Stephane Bancel, in an interview at a Goldman Sachs event yesterday, said a fourth dose may be necessary at some point because the protection provided by boosters also is likely to decline over time.
    “I will be surprised when we get that data in the coming weeks that it’s holding nicely over time — I would expect that it’s not going to hold great,” Bancel said, referring to the strength of the booster shots.
    The U.K. Health Security agency found booster protection starts to decline after about four weeks. Boosters were 55% to 70% effective at preventing infection at weeks five to nine, and 40% to 50% effective 10 weeks after receiving the shot, according to the U.K. agency report.
    Pfizer CEO Albert Bourla told CNBC last month that people will likely need a fourth dose, and the shot may be needed sooner than expected due to omicron’s virulence.
    The U.S. is currently facing an unprecedented wave of Covid infections, with a seven-day average of more than 600,000 new cases daily, according to a CNBC analysis of data from Johns Hopkins University. That’s a 72% increase from the previous week and a pandemic record.

    CNBC Health & Science

    WATCH LIVEWATCH IN THE APP More

  • in

    Pfizer Covid vaccine protects adolescents against multisystem inflammatory syndrome, CDC says

    The Centers for Disease Control and Prevention found the Pfizer vaccine was 91% effective at protecting adolescents from multisystem inflammatory syndrome, or MIS-C.
    MIS-C is strongly linked to Covid infection and afflicts the heart, lung, kidneys, brain, skin, eyes or gastrointestinal organs.
    The CDC study was conducted when delta was the predominant variant.

    Safeway pharmacist Ashley McGee fills a syringe with the Pfizer COVID-19 booster vaccination at a vaccination booster shot clinic on October 01, 2021 in San Rafael, California.
    Justin Sullivan | Getty Images

    Two doses of Pfizer and BioNTech’s vaccine are highly effective at protecting children 12 to 18 from a severe inflammatory condition associated with Covid infection, a new study found.
    The Centers for Disease Control and Prevention, in a report published Friday, found that Pfizer’s vaccination was 91% effective at protecting adolescents against multisystem inflammatory syndrome, or MIS-C.

    The CDC study looked at 283 hospitalized patients ages 12 to 18 across 24 pediatric hospitals in 20 states from July through December 2021 when delta was the predominant variant. The analysis focused on the 12- to 18-year age group because Pfizer shots weren’t available to younger kids until November.
    The CDC noted that vaccine efficacy against MIS-C caused by the omicron variant, which is now dominant in the U.S., could not be determined due to the timing of the study.

    CNBC Health & Science

    MIS-C is a serious condition in which different parts of the body become inflamed, such as the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs. Children usually develop MIS-C two to six weeks after an asymptomatic or mild Covid infection, according to the CDC.

    More than 6,000 children have developed MIS-C since May 2020 and 55 have died, according to CDC data. The majority of MIS-C patients are Hispanic or Black, most are boys and half are between 5 and 13 years old. Of the known MIS-C cases, 98% tested positive for Covid while 2% had exposure to the virus, according to the CDC.
    The CDC study compared 102 hospitalized MIS-C patients with 181 patients who either tested negative for Covid or did not have symptoms. The overwhelming majority of MIS-C patients, 95%, were unvaccinated. None of the five fully vaccinated MIS-C patients required life support, while 39% of unvaccinated MIS-C patients did need life support.

    “This analysis lends supportive evidence that vaccination of children and adolescents is highly protective against MIS-C and Covid-19 and underscores the importance of vaccination of all eligible children,” the CDC concluded in its Morbidity and Mortality Weekly Report.
    Children ages 5 and up are now eligible to receive the two-dose Pfizer vaccine. Adolescents ages 12 and up are eligible for Pfizer booster shots at least five months after their second dose.

    WATCH LIVEWATCH IN THE APP More

  • in

    Pixar's 'Turning Red' to skip theaters, head straight to Disney+ in March

    Pixar’s “Turning Red” will skip theaters and head straight to Disney+ this March.
    It is the third Pixar film to transition to Disney’s streaming platform during the pandemic.
    The move isn’t too surprising considering families have been slow to return to theaters, even after vaccinations became widely available to children. In fact, no animated film has surpassed $100 million domestically since March 2020.

    Still from Pixar’s “Turning Red.”

    Another Pixar film is heading straight to Disney+.
    On Friday, Disney announced that is newest animated feature “Turning Red” would skip theaters and debut exclusively for free on its streaming service on March 11.

    The family-friendly film about a young girl that transforms into a giant red panda whenever she gets too excited will follow the same path other Pixar films “Soul” and “Luca” took during the Covid-19 pandemic.
    The move isn’t too surprising considering families have been slow to return to theaters, even after vaccinations became widely available to children. In fact, no animated film has surpassed $100 million domestically since March 2020.
    The top earners so far have been Universal’s “Sing 2,” released in late December, which has tallied $97 million and Disney’s “Encanto,” released over the Thanksgiving holiday, which has garnered around $92 million in ticket sales, according to data from Comscore.
    “Given the delayed box office recovery, particularly for family films, flexibility remains at the core of our distribution decisions as we prioritize delivering the unparalleled content of The Walt Disney Company to audiences around the world,” said Kareem Daniel, chairman of Disney’s media and entertainment distribution, in a statement obtained by Variety.
    Representatives for Disney did not immediately respond to CNBC’s request for comment.

    “Turning Red” is directed by Domee Shi, who created the Pixar short “Bao.” The film marks the first time that a Pixar project has been solely directed by a woman.
    Disclosure: Comcast is the parent company of NBCUniversal and CNBC.

    WATCH LIVEWATCH IN THE APP More